Protein kinase C regulatory domain surrogate peptides: Effects of metal ions on folding, phorbol ester-binding, and selectivity

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 8, 1997, Pages 965-970

  Irie, Kazuhiro ^a   Yanai, Yoshiaki ^a   Oie, Kentaro ^a   Ohigashi, Hajime ^a   Wender, Paul A ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADMIUM; COPPER; GOLD; MERCURY; PHORBOL ESTER; PROTEIN KINASE C; SILVER; SYNTHETIC PEPTIDE; ZINC;

ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; ENZYME BINDING; ENZYME STRUCTURE; IN VITRO STUDY; MODEL; NONHUMAN; PROTEIN DOMAIN; PROTEIN FOLDING; RAT; SPECTROPHOTOMETRY;

EID: 0030969351     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00140-6     Document Type: Article

References (28)

1. Nishizuka, Y. Nature 1984, 308, 693-698.
2. Quest, A. F. G.; Bardes, E. S. G.; Bell, R. M. J. Biol. Chem. 1994, 269, 2961-2970.
3. Wender, P. A.; Irie, K.; Miller, B. L. Proc. Natl. Acad. Sci. USA 1995, 92, 239-243.
4. Kazanietz, M. G.; Barchi, J. J.; Omichinski, J. G.; Blumberg, P. M. J. Biol. Chem. 1995, 270, 14679-14684.
5. Irie, K.; Yanai, Y.; Ohigashi, H.; Wender, P. A.; Miller, B. L. Bioorg. Med. Chem. Lett. 1996, 6, 353-356.
6. Yanai, Y.; Irie, K.; Ohigashi, H.; Wender, P. A. Bioorg. Med. Chem. Lett. 1997, 7, 117-122.
7. Hubbard, S. R.; Bishop, W. R.; Kirschmeier, P.; George, S. J.; Cramer, S. P.; Hendrickson, W. A. Science 1991, 254, 1776-1779.
8. Quest, A. F. G.; Bloomenthal, J.; Bardes, E. S. G.; Bell, R. M. J. Biol. Chem. 1992, 267, 10193-10197.
9. Hommel, U.; Zurini, M.; Luyten, M. Nat. Struct. Biol. 1994, 1, 383-387.
10. Ichikawa, S.; Hatanaka, H.; Takeuchi, Y.; Ohno, S.; Inagaki, F. J. Biochem. 1995, 117, 566-574.
11. For a review, see: Klug, A.; Schwabe, J. W. R. FASEB J. 1995, 9, 597-604.
12. Irie, K.; Isaka, T.; Iwata, Y.; Yanai, Y.; Nakamura, Y.; Koizumi, F.; Ohigashi, H.; Wender, P. A.; Satomi, Y.; Nishino, H. J. Am. Chem. Soc. 1996, 118, 10733-10743.
13. 4 Careful examination on the pH dependence of the PDBu binding indicated that the optimal pH for maximum binding is between 5.0 and 6.5 (data not shown). Folding studies conducted at pH values greater than 8 did not show any PDBu binding.
14. 7,8 Since 2.5-molar equivalents of zinc gave maximum binding, 5-molar equivalents of zinc or other metal salts were used in the folding of the peptides. An almost linear concentration dependence on the binding was observed at less than 2-molar equivalents of zinc or cadmium.
15. Sharkey, N. A.; Blumberg, P. M. Cancer Res. 1985, 45, 19-24.
16. For a review, see: Nishizuka, Y. FASEB J. 1995, 9, 484-496.
17. Zhang, G.; Kazanietz, M. G.; Blumberg, P. M.; Hurley, J. H. Cell 1995, 81, 917-924.
18. Irie, K.; Ishii, T.; Ohigashi, H.; Wender, P. A.; Miller, B. L.; Takeda, N. J. Org. Chem. 1996, 61, 2164-2173.
19. Matthies, H. J. G.; Palfrey, H. C.; Hirning, L. D.; Miller, R. J. J. Neurosci. 1987, 7, 1198-1206.
20. Nichols, R. A.; Haycock, J. W.; Wang, J. K. T.; Greengard, P. J. Neurochem. 1987, 48, 615-621.
21. Weiss, S.; Ellis, J.; Hendley, D. D.; Lenox, R. H. J. Neurochem. 1989, 52, 530-536.
22. For a review, see: Nishizuka, Y. Science 1992, 258, 607-614.
23. Speizer, L. A.; Watson, M. J.; Kanter, J. R.; Brunton, L. L. J. Biol. Chem. 1989, 264, 5581-5585.
24. Rajanna, B.; Chetty, C. S.; Rajanna, S.; Hall, E.; Fail, S.; Yallapragada, P. R. Toxicol. Lett. 1995, 81, 197-203.
25. Saijoh, K.; Inoue, Y.; Katsuyama, H.; Sumino, K. Pharmacol. Toxicol. 1988, 63, 221-224.
26. Murakami, K.; Feng, G.; Chen, S. G. J. Pharmacol. Exp. Ther. 1993, 264, 757-761.
27. Krizek, B. A.; Berg, J. M. Inorg. Chem. 1992, 31, 2984-2986.
28. Yang, J. T.; Wu, C.-S. C.; Martinez, H. M. Methods Enzymol. 1986, 130, 208-269.